# Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic

> **NCT04404244** · — · COMPLETED · sponsor: **Fatma Soliman Elsayed Ebeid, MD** · enrollment: 800 (actual)

## Conditions studied

- Coronavirus COVID-19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04404244
- **Lead sponsor:** Fatma Soliman Elsayed Ebeid, MD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2023-11-01
- **Final completion:** 2024-01-01
- **Target enrollment:** 800 (ACTUAL)
- **Last updated:** 2024-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04404244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04404244, "Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04404244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*